EUVIMEDEUVIMED entdecken
Crossref

A Label‐Free Bioluminescent scFv‐NLuc Fusion Probe Enabling a Smartphone‐Based Sensitive Immunoassay Platform Using Lomefloxacin as a Model Analyte

Mingyue Ding, Hao Wen, Shixiang Wu iD, Shiyun Han, Linwei Zhang, Hongfei Yang, Xu Wang, Long Li, Dapeng Peng iD

Small · 2026

DOI: 10.1002/smll.75027 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Small, 2026. Verfasst von Mingyue Ding und 8 weiteren Autor:innen. Beteiligte Einrichtung: National Reference Laboratory of Veterinary Drug Residues (HZAU) and MOA Key Laboratory For the Detection of Veterinary Drug Residues, Huazhong Agric…. Hauptthemen laut MEDLINE: Smartphone, Fluoroquinolones, Single-Chain Antibodies, Luminescent Measurements. Die Arbeit nennt 35 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Programs of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Enzymes as labeling agents enhance lateral flow immunoassays (LFIA). However, their biological instability and reliance on labor‐intensive chemical conjugation hinder practical high‐throughput screening of food contaminants. To address this, we report a rapid, label‐free luciferase‐based platform for quantifying lomefloxacin (LOM) in food. The assay uses an engineered immunoprobe: a high‐affinity single‐chain variable fragment antibody (3G9‐scFv) specific to LOM, combined with Nanoluciferase (NLuc) as an intrinsic signal generator without covalent labeling. NLuc catalyzes furimazine oxidation, producing stable bioluminescence inversely proportional to LOM concentration. This label‐free design eliminates conjugation variability and simplifies protocol execution. Smartphone‐based luminescence measurement enables sensitive field detection, with a limit of quantification of 0.12 ng/mL. Furthermore, homology modeling and molecular docking elucidated the structural basis for the dual functionality of 3G9‐scFv, validating the rational use of unlabeled enzymatic tracers. The visual detection limit was determined to be 1 ng/mL. Recovery rates ranged from 79.0% to 113.0%, with coefficients of variation (CVs) between 2.3% and 10.9%, indicating high accuracy and reproducibility. This system offers a novel rapid detection platform for monitoring hazardous residues in food safety.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SmartphoneFluoroquinolonesSingle-Chain AntibodiesLuminescent MeasurementsLuciferasesImmunoassayMolecular Docking Simulation

Stichwörter der Autor:innen

bioluminescencelateral flow immunoassaysnanoluciferaserecombinant antibody

Substanzen

FluoroquinolonesSingle-Chain AntibodieslomefloxacinLuciferases

Autor:innen und Institutionen

  • National Reference Laboratory of Veterinary Drug Residues (HZAU) and MOA Key Laboratory For the Detection of Veterinary Drug Residues, Huazhong Agricultural University, Wuhan, China.
  • Zhejiang Provincial Engineering Research Center of Animal Biological Products, Center For Veterinary Sciences, Zhejiang University, Hangzhou, Zhejiang, China.

ORCID-Profile: Shixiang Wu, Dapeng Peng

Förderung

  • National Natural Science Foundation of China
  • National Key Research and Development Programs of China

Zitieren

APA

Ding, M., Wen, H., Wu, S., Han, S., Zhang, L., Yang, H., Wang, X., Li, L., & Peng, D. (2026). A Label‐Free Bioluminescent scFv‐NLuc Fusion Probe Enabling a Smartphone‐Based Sensitive Immunoassay Platform Using Lomefloxacin as a Model Analyte. Small. https://doi.org/10.1002/smll.75027

Vancouver

Ding M, Wen H, Wu S, Han S, Zhang L, Yang H, et al. A Label‐Free Bioluminescent scFv‐NLuc Fusion Probe Enabling a Smartphone‐Based Sensitive Immunoassay Platform Using Lomefloxacin as a Model Analyte. Small. 2026. doi:10.1002/smll.75027

BibTeX
@article{Ding2026,
  author = {Ding, Mingyue and Wen, Hao and Wu, Shixiang and Han, Shiyun and Zhang, Linwei and Yang, Hongfei and Wang, Xu and Li, Long and Peng, Dapeng},
  title = {A Label‐Free Bioluminescent scFv‐NLuc Fusion Probe Enabling a Smartphone‐Based Sensitive Immunoassay Platform Using Lomefloxacin as a Model Analyte},
  journal = {Small},
  year = {2026},
  doi = {10.1002/smll.75027}
}
Kostenlos starten →